NCT04924335

Brief Summary

Surgery-induced pain reveals its own metabolic and inflammatory responses, resulting in a further increase in noxious pathways that are already occurring. Even though it is difficult to distinguish whether the metabolic and inflammatory responses are pain-induced or surgical-induced, it is clear that pain can cause a response. This study aims to investigate the effects of erector spinae plane block on surgery-related stress response with enhanced recovery after cardiac surgery protocol.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
70

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Mar 2021

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2021

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

May 22, 2021

Completed
23 days until next milestone

First Posted

Study publicly available on registry

June 14, 2021

Completed
17 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2021

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2021

Completed
Last Updated

August 20, 2021

Status Verified

August 1, 2021

Enrollment Period

4 months

First QC Date

May 22, 2021

Last Update Submit

August 17, 2021

Conditions

Keywords

erector spinae plane blockcardiac surgeryenhanced recovery after surgery programlactatestress responsec reactive protein

Outcome Measures

Primary Outcomes (10)

  • Basal measurements- after anesthesia induction

    After induction of anesthesia, blood gas analysis will be performed and lactate level (mmol/L) will be recorded.

    After anesthesia induction, an average of 5 minutes

  • Basal measurements- after anesthesia induction

    After induction of anesthesia, blood gas analysis will be performed and hemoglobin level (g/dL) will be recorded.

    After anesthesia induction, an average of 5 minutes

  • Second measurements- after cardiopulmonary bypass initiation

    After cardiopulmonary bypass initiation, blood gas analysis will be performed and lactate level (mmol/L) will be recorded.

    After cardiopulmonary bypass inititation, an average of 5 minutes

  • Second measurements- after cardiopulmonary bypass initiation

    After cardiopulmonary bypass initiation, blood gas analysis will be performed and hemoglobin level (g/dL) will be recorded.

    After cardiopulmonary bypass inititation, an average of 5 minutes

  • Third measurements- during cardiopulmonary bypass, at lowest temperature

    During cardiopulmonary bypass, at lowest temperature, blood gas analysis will be performed and lactate level (mmol/L) will be recorded.

    During cardiopulmonary bypass, an average of 10 minutes

  • Third measurements- during cardiopulmonary bypass, at lowest temperature

    During cardiopulmonary bypass, at lowest temperature, blood gas analysis will be performed and hemoglobin level (g/dL) will be recorded.

    During cardiopulmonary bypass, an average of 10 minutes

  • Fourth measurements- end of cardiopulmonary bypass

    At the end of cardiopulmonary bypass, blood gas analysis will be performed and lactate level (mmol/L) will be recorded.

    At the end of cardiopulmonary bypass, an average of 10 minutes

  • Fourth measurements- end of cardiopulmonary bypass

    At the end of cardiopulmonary bypass, blood gas analysis will be performed and hemoglobin level (g(dL) will be recorded.

    At the end of cardiopulmonary bypass, an average of 10 minutes

  • Fifth measurements- end of surgery

    At the end of surgery, blood gas analysis will be performed and lactate level (mmol/L) will be recorded.

    At the end of surgery, an average of 20 minutes

  • Fifth measurements- end of surgery

    At the end of surgery, blood gas analysis will be performed and hemoglobin level (g/dL) will be recorded.

    At the end of surgery, an average of 20 minutes

Secondary Outcomes (5)

  • Preoperative complete blood count

    The day before surgery, 24 hours

  • Preoperative albumin

    The day before surgery, 24 hours

  • Postoperative C reactive protein

    6 hours after surgery

  • Postoperative complete blood count

    6 hours after surgery

  • Postoperative albumin

    6 hours after surgery

Study Arms (2)

ESP group

ACTIVE COMPARATOR

ESP group patients will be performed ultrasound-guided erector spinae plane block with 20 ml 0.025% Bupivacaine, preoperatively and will receive ERAS cardiac anesthesia protocol

Procedure: Erector spinae plane block

Conventional group

NO INTERVENTION

The conventional group will receive ERAS cardiac anesthesia protocol

Interventions

Preoperative ultrasound-guided bilateral erector spinae plane block with 20 ml 0.025% bupivacaine.

ESP group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adult patients who will undergo open-heart surgery with ERAS protocol

You may not qualify if:

  • Emergency surgeries
  • Patients with allergic reactions to anesthesia and analgesia drugs to be used
  • Patients who do not want to participate in the study voluntarily
  • Severe systemic disease (kidney, liver, pulmonary, endocrine)
  • Substance abuse history
  • History of chronic pain
  • Psychiatric problems and communication difficulties
  • Patients who need revision due to hemostasis in the postoperative period
  • Patients with severe hemodynamic instability due to infection, heavy bleeding, etc.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ankara City Hospital

Ankara, Select State/Province, 06800, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Fractures, Stress

Condition Hierarchy (Ancestors)

Fractures, BoneWounds and Injuries

Study Officials

  • Serdar Günaydın, Professor

    Ankara City Hospital Bilkent

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Medical Doctor

Study Record Dates

First Submitted

May 22, 2021

First Posted

June 14, 2021

Study Start

March 1, 2021

Primary Completion

July 1, 2021

Study Completion

August 1, 2021

Last Updated

August 20, 2021

Record last verified: 2021-08

Locations